Army Department July 12, 2010 – Federal Register Recent Federal Regulation Documents

Notice of Availability of Final Environmental Impact Statement for the Proposed Rio del Oro Specific Plan Project, in Sacramento County, CA, Corps Permit Application number SPK-1999-00590
Document Number: 2010-16899
Type: Notice
Date: 2010-07-12
Agency: Department of Defense, Department of the Army, Corps of Engineers, Engineers Corps, Army Department
Pursuant to the National Environmental Policy Act (NEPA), the U.S. Army Corps of Engineers (USACE), Sacramento District has prepared a Final Environmental Impact Statement (FEIS) for the Rio del Oro Specific Plan Project, a proposed master-planned, mixed use development within south-eastern Sacramento County.
Availability for Non-Exclusive or Partially Exclusive Licensing of a U.S. Patent Application
Document Number: 2010-16897
Type: Notice
Date: 2010-07-12
Agency: Department of Defense, Department of the Army, Army Department
Announcement is made of the availability for licensing of the invention set forth in U.S. Patent Application Serial No. 11/727,486, entitled ``Artificial Invaplex,'' filed March 27, 2007. Foreign rights are also available for licensing (PCT/US2007/007482). The United States Government, as represented by the Secretary of the Army, has rights to this invention.
Availability for Non-Exclusive or Partially Exclusive Licensing of a U.S. Patent Application
Document Number: 2010-16894
Type: Notice
Date: 2010-07-12
Agency: Department of Defense, Department of the Army, Army Department
Announcement is made of the availability for licensing of the invention set forth in U.S. Patent Application Serial No. 12/149,076, entitled ``Combinations of Gene Deletions for Live Attenuated Shigella Vaccine Strains,'' filed April 25, 2008. Foreign rights are also available for licensing (PCT/US2008/005342). The United States Government, as represented by the Secretary of the Army, has rights to this invention.
Availability for Non-Exclusive or Partially Exclusive Licensing of a U.S. Patent Application
Document Number: 2010-16891
Type: Notice
Date: 2010-07-12
Agency: Department of Defense, Department of the Army, Army Department
Announcement is made of the availability for licensing of the invention set forth in U.S. Patent Application Serial No. 11/132,199, entitled ``Construction of Live Attenuated Shigella Vaccine Strains that Express CFA/I Antigens (CFAB and CFAE) and the B Subunit of Heat- Labile Enterotoxin (LTB) From Enterotoxigenic E. Coli,'' filed May 19, 2005. The United States Government, as represented by the Secretary of the Army, has rights to this invention.
Availability for Non-Exclusive or Partially Exclusive Licensing of a U.S. Patent Application
Document Number: 2010-16889
Type: Notice
Date: 2010-07-12
Agency: Department of Defense, Department of the Army, Army Department
Announcement is made of the availability for licensing of the invention set forth in U.S. Patent 7,632,659, which issued on December 15, 2009, entitled ``Use of Shigella Invaplex to Transport Functional Proteins and Transcriptionally Active Nucleic Acids Across Mammalian Cell Membranes In Vitro and In Vivo,'' and U.S. Patent Application Serial No. 12/563,794, entitled ``Use of Shigella Invaplex to Transport Functional Proteins and Transcriptionally Active Nucleic Acids Across Mammalian Cell Membranes In Vitro and In Vivo,'' filed September 21, 2009. U.S. Patent Application Serial No. 12/563,794 is a continuation application of U.S. Patent 7,632,659. Foreign rights are also available for licensing (PCT/US2004/039100). The United States Government, as represented by the Secretary of the Army, has rights to this invention.
Intent To Grant a Field of Use Exclusive License of a U.S. Government-Owned Patent Application
Document Number: 2010-16887
Type: Notice
Date: 2010-07-12
Agency: Department of Defense, Department of the Army, Army Department
In accordance with 35 U.S.C. 209(e), and 37 CFR 404.7(a)(1)(i), announcement is made of the intent to grant a field of use exclusive, revocable license for the field of shigella vaccine development to U.S. Patent Application No. 11/727,486 entitled ``Artificial Invaplex,'' filed March 27, 2007, and related foreign patent applications (PCT/US2007,007482) to Sanofi Pasteur S.A., with its principal place of business at 2 Avenue du Pont Pasteur, 69007 Lyon, France.